Q: (But ?) the CMS study from February predicted a 6.1-percent increase, and now, post-health care, 6.3percentt.
In the second round of CMS study animals in both the stress and control groups of 10 animals per group were treated daily with the CB2 antagonist AM630 ( 1 and 3 mg/kg) and the control groups with the vehicle for 4 weeks.
We then entered the risk factors (dependent variable) derived from the CMS study [ 5] in a stepwise logistic regression analysis for each of the QIs (independent variable) and calculated the Odds Ratios for the risk factors in the SHELTER sample.
This result occurred because staffing effects on hospitalizations, though statistically significant as reported in the CMS study, were small in magnitude (we estimated a reduction in 30-day hospital transfer rates from 16%to14.7%7% based on the CMS data).
Granzyme A and TNF decoy receptor tnfrsf6b, which were also down-regulated by the functional feeds, showed strongest correlation with heart histopathology level in a previous CMS study [ 11].
In our previous CMS study focusing on the most severely diseased fish, we also concluded that the same responses were possibly associated with an observed viral clearance and reduced pathology later on (10 12 weeks post infection) [ 10].
